untitled
<OAI-PMH schemaLocation=http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd>
<responseDate>2018-01-15T18:17:43Z</responseDate>
<request identifier=oai:HAL:hal-01509592v1 verb=GetRecord metadataPrefix=oai_dc>http://api.archives-ouvertes.fr/oai/hal/</request>
<GetRecord>
<record>
<header>
<identifier>oai:HAL:hal-01509592v1</identifier>
<datestamp>2018-01-11</datestamp>
<setSpec>type:ART</setSpec>
<setSpec>subject:sdv</setSpec>
<setSpec>collection:CNRS</setSpec>
<setSpec>collection:UNIV-PICARDIE</setSpec>
<setSpec>collection:UNIV-AG</setSpec>
<setSpec>collection:UNIV-FCOMTE</setSpec>
<setSpec>collection:CHRONO-ENVIRONNEMENT</setSpec>
<setSpec>collection:BS</setSpec>
<setSpec>collection:UNIV-MONTPELLIER</setSpec>
</header>
<metadata><dc>
<publisher>HAL CCSD</publisher>
<title lang=en>Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.</title>
<creator>Faucher, Jean-François</creator>
<creator>Morquin, David</creator>
<creator>Reynes, Jacques</creator>
<creator>Chirouze, Catherine</creator>
<creator>Hoen, Bruno</creator>
<creator>Le Moing, Vincent</creator>
<contributor>Université de Picardie Jules Verne (UPJV)</contributor>
<contributor>Centre Hospitalier Universitaire de Montpellier (CHU Montpellier )</contributor>
<contributor>Département Maladies Infectieuses et Tropicales, Hôpital Universitaire, Montpellier, France</contributor>
<contributor>Laboratoire Chrono-environnement (LCE) ; Université Bourgogne Franche-Comté (UBFC) - Centre National de la Recherche Scientifique (CNRS) - Université de Franche-Comté (UFC)</contributor>
<contributor>Service des maladies infectieuses et tropicales ; Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon) - Hôpital Saint-Jacques</contributor>
<contributor>Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)</contributor>
<contributor>Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane) ; Université des Antilles et de la Guyane (UAG) - Institut National de la Santé et de la Recherche Médicale (INSERM) - CHU de Pointe-à-Pitre - Centre Hospitalier de Cayenne Andrée Rosemon - CHU de Fort de France</contributor>
<contributor>Recherches Translationnelles sur le VIH et les maladies infectieuses (TransVIHMI) ; Université Montpellier 1 (UM1) - Université Cheikh Anta Diop (UCAD) - Universtié Yaoundé 1 (Cameroun) - Université de Montpellier (UM)</contributor>
<description>International audience</description>
<source>ISSN: 1383-5769</source>
<source>Parasitology International</source>
<publisher>Elsevier</publisher>
<identifier>hal-01509592</identifier>
<identifier>https://hal.archives-ouvertes.fr/hal-01509592</identifier>
<source>https://hal.archives-ouvertes.fr/hal-01509592</source>
<source>Parasitology International, Elsevier, 2016, 65 (5), pp.444-6</source>
<identifier>PUBMED : 27353022</identifier>
<relation>info:eu-repo/semantics/altIdentifier/pmid/27353022</relation>
<language>en</language>
<subject lang=en>Aids</subject>
<subject lang=en>Liposomal amphotericin B</subject>
<subject lang=en>Miltefosine</subject>
<subject lang=en>Pentamidine</subject>
<subject lang=en>Visceral leishmaniasis</subject>
<subject>[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology</subject>
<type>info:eu-repo/semantics/article</type>
<type>Journal articles</type>
<description lang=en>Liposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral leishmaniasis (VL) in the immunodeficient host. There are currently no guidelines on how to treat such patients and efficacy of miltefosine monotherapy seems limited in this indication. We present 2 cases of patients with VL and AIDS for which LAmb had to be interrupted (one because of toxicity, one because of treatment failure) and who were treated effectively with pentamidine followed by miltefosine.</description>
<date>2016-07-11</date>
</dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
